Published Date: 17 Feb 2023
A man takes a small pill before hoping to flirt with his girlfriend.
Read Full NewsFor men with intermediate-risk prostate cancer, SBRT may beat longer-course radiotherapy in some measures of quality of life, but not disease-free survival.
Weekly electronic symptom monitoring was associated with improved fatigue and physical functioning in a randomized trial of patients with metastatic breast cancer.
Outcomes improve when a novel, first-in-class immunomodulatory drug is combined with daratumumab and dexamethasone in previously treated patients.
1.
Pulled Myeloma Drug Improves Survival in Trial
2.
AZD0486 Shows Good Efficacy in Relapsed/Refractory Follicular Lymphoma
3.
OA Tied to Arthritis AE Risk in ICI-Treated Patients
4.
Admissions, medical schools, costs, and eligibility requirements information for FNB Onco-Anesthesia.
5.
Can Concurrent Boost Safely Shorten Breast Cancer Radiation?
1.
Transformative Directions in Hematology in Clinical Decision-Making
2.
Surgical Innovation Using Tumor-Adaptive Surgical Resection Strategies
3.
Survivin as a Key Regulator in Gynecological Cancers: Therapeutic and Prognostic Implications
4.
What Is May-Hegglin Anomaly? Understanding this Rare Blood Disorder
5.
Theranostics and Radioligand Therapy: Precision Cancer Care with Targeted Radionuclides
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
1.
The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
2.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia- Important Points to Know
3.
CDK4/6 Inhibitors Redefining Treatment for HR+/HER2- aBC In Post-Menopausal Women- A Panel Discussion
4.
Learning About Different Treatment Approaches For Acute Lymphoblastic Leukemia
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation